ELEVATION ONCOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.61 USD | 0.00% |
|
+10.06% | +572.25% |
| May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
| May. 02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ELEVATION ONCOLOGY, INC. | Bio Therapeutic Drugs | 0.00% | +10.06% | +572.25% | -28.66% | - | 197M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ELEV Stock
- Charts Elevation Oncology, Inc.
- Comparison Chart